A bill to require reporting on prescription drug expenditures under group health plans and on prescription drug price changes, and for other purposes.
Prescription Drug Price Reporting Act
This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.
HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
Referred to the Subcommittee on Health.
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line